By Josh White
Date: Tuesday 02 Jan 2024
LONDON (ShareCast) - (Sharecast News) - Genedrive confirmed a planned £0.6m drawdown as part of its £5m equity prepayment facility on Tuesday, which it initially disclosed on 31 March 2023.
The AIM-traded firm said that as a result, investors would be issued 3,093,915 warrants, representing 40% of the drawdown's value divided by the reference price of 7.7572p.
It said the warrants would have an exercise price of 140% of the reference price, equating to 10.86p.
At 1336 GMT, shares in Genedrive were down 0.92% at 8.05p.
Reporting by Josh White for Sharecast.com.
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 5.38p |
Change Today | -0.25p |
% Change | -4.44 % |
52 Week High | 22.25 |
52 Week Low | 3.13 |
Volume | 1,268,108 |
Shares Issued | 143.14m |
Market Cap | £7.69m |
RiskGrade | 747 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:29 | 36 @ 5.50p |
16:21 | 5,000 @ 5.45p |
16:07 | 4,956 @ 5.28p |
15:30 | 94,320 @ 5.31p |
14:37 | 2,000 @ 5.50p |
You are here: research